You are here
Agility Health Announces Management Cease Trade Order Update
GRAND RAPIDS, Mich., May 15, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility Health” or “Corporation”), today is providing an update with respect to the management cease trade order issued by the Ontario Securities Commission on May 1, 2018 in connection with the delay by the Corporation in filing its audited annual financial statements, management’s discussion and analysis and related officer certifications for the financial year ended December 31, 2017 (collectively, the “Annual Filings”) beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 Continuous Disclosure Obligations and pursuant to National Instrument 52-109 Certification of Disclosure in Issuer’s Annual and Interim Filings, being April 30, 2018.
The Corporation continues to work diligently with its auditor and expects to file the Annual Filings as soon as possible and in any event no later than May 30, 2018. The Corporation anticipates that it may be delayed in filing its interim financial statements, management’s discussion and analysis, and the related officer certifications for the financial period ended March 31, 2018 (the “Q1 Filings”) which are required to be filed on May 30, 2018. The Corporation intends on filing an application for a management cease trade order under National Policy 12-203 Management Cease Trade Orders (“NP 12-203”) with respect to the Q1 Filings.
The Corporation is providing this status update in accordance with NP 12-203. The Corporation intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Corporation remains in default. The Corporation confirms as of the date of this news release that there has been no material change in the information contained in the default announcement issued April 27, 2018 and there is no other material information concerning the affairs of the Corporation that has not been generally disclosed.
About Agility Health
Through its Canadian subsidiary and principal operating entity, Medic Holdings Corp., Agility Health operates eleven (11) foot care clinics in Ontario and Quebec and manufactures orthotics and prosthetics.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This release includes forward-looking statements regarding Agility Health and its business. Such statements are based on the current expectations and views of future events of Agility Health’s management. In some cases the forward-looking statements can be identified by words or phrases such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify forward-looking statements. The forward-looking events and circumstances discussed in this release, including the anticipated future growth of Agility Health, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the company. No forward-looking statement can be guaranteed. Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Accordingly, readers should not place undue reliance on any forward-looking statements or information. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Agility Health undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
For further information please contact:
Interim Chief Executive Officer